Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs

Feline infectious peritonitis (FIP) is a fatal disease classified as either effusive, non-effusive (‘dry’), or a mixture (‘mixed’) of the forms of FIP, with mixed showing signs of both effusive and dry. To determine whether the therapeutic effect of Mutian on dry and mixed FIP can be predicted using...

Full description

Bibliographic Details
Main Authors: Masato Katayama, Yukina Uemura
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Veterinary Sciences
Subjects:
Online Access:https://www.mdpi.com/2306-7381/10/2/136
_version_ 1797617888686768128
author Masato Katayama
Yukina Uemura
author_facet Masato Katayama
Yukina Uemura
author_sort Masato Katayama
collection DOAJ
description Feline infectious peritonitis (FIP) is a fatal disease classified as either effusive, non-effusive (‘dry’), or a mixture (‘mixed’) of the forms of FIP, with mixed showing signs of both effusive and dry. To determine whether the therapeutic effect of Mutian on dry and mixed FIP can be predicted using clinical indicators before starting treatment, we entered 161 cats with mixed FIP and 163 cats with dry FIP into this study. Physical assessments, the reverse transcriptase-PCR detection of viral genes, and clinical laboratory tests (hematocrit, albumin/globulin ratio, serum amyloid A, α1-acid glycoprotein, and total bilirubin) were performed before Mutian was administered. These indicators were compared between the FIP groups that survived after receiving Mutian for 84 days and those that died before the completion of treatment. Significant differences in body temperature, appetite, and activity scores were confirmed between the surviving and non-surviving groups. The therapeutic effect was insufficient when total bilirubin levels increased in cats with the mixed form. In both of the FIP types, therapeutic effects were difficult to obtain when neurological clinical signs were observed. The therapeutic effects of Mutian on the cats with dry and mixed FIP can be predicted based on pre-treatment body temperature, appetite scores, and activity scores, as well as the presence of neurological signs.
first_indexed 2024-03-11T08:02:21Z
format Article
id doaj.art-ef421748c0134e7c90522c471575a322
institution Directory Open Access Journal
issn 2306-7381
language English
last_indexed 2024-03-11T08:02:21Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Veterinary Sciences
spelling doaj.art-ef421748c0134e7c90522c471575a3222023-11-16T23:46:07ZengMDPI AGVeterinary Sciences2306-73812023-02-0110213610.3390/vetsci10020136Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical SignsMasato Katayama0Yukina Uemura1Bloom Animal Hospital, Kajiyama 1-10-32, Tsurumi, Yokohama City 230-0072, JapanBloom Animal Hospital, Kajiyama 1-10-32, Tsurumi, Yokohama City 230-0072, JapanFeline infectious peritonitis (FIP) is a fatal disease classified as either effusive, non-effusive (‘dry’), or a mixture (‘mixed’) of the forms of FIP, with mixed showing signs of both effusive and dry. To determine whether the therapeutic effect of Mutian on dry and mixed FIP can be predicted using clinical indicators before starting treatment, we entered 161 cats with mixed FIP and 163 cats with dry FIP into this study. Physical assessments, the reverse transcriptase-PCR detection of viral genes, and clinical laboratory tests (hematocrit, albumin/globulin ratio, serum amyloid A, α1-acid glycoprotein, and total bilirubin) were performed before Mutian was administered. These indicators were compared between the FIP groups that survived after receiving Mutian for 84 days and those that died before the completion of treatment. Significant differences in body temperature, appetite, and activity scores were confirmed between the surviving and non-surviving groups. The therapeutic effect was insufficient when total bilirubin levels increased in cats with the mixed form. In both of the FIP types, therapeutic effects were difficult to obtain when neurological clinical signs were observed. The therapeutic effects of Mutian on the cats with dry and mixed FIP can be predicted based on pre-treatment body temperature, appetite scores, and activity scores, as well as the presence of neurological signs.https://www.mdpi.com/2306-7381/10/2/136FIPcatnucleotide analoguetotal bilirubinneurologic clinical sign
spellingShingle Masato Katayama
Yukina Uemura
Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs
Veterinary Sciences
FIP
cat
nucleotide analogue
total bilirubin
neurologic clinical sign
title Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs
title_full Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs
title_fullStr Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs
title_full_unstemmed Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs
title_short Prognostic Prediction for Therapeutic Effects of Mutian on 324 Client-Owned Cats with Feline Infectious Peritonitis Based on Clinical Laboratory Indicators and Physical Signs
title_sort prognostic prediction for therapeutic effects of mutian on 324 client owned cats with feline infectious peritonitis based on clinical laboratory indicators and physical signs
topic FIP
cat
nucleotide analogue
total bilirubin
neurologic clinical sign
url https://www.mdpi.com/2306-7381/10/2/136
work_keys_str_mv AT masatokatayama prognosticpredictionfortherapeuticeffectsofmutianon324clientownedcatswithfelineinfectiousperitonitisbasedonclinicallaboratoryindicatorsandphysicalsigns
AT yukinauemura prognosticpredictionfortherapeuticeffectsofmutianon324clientownedcatswithfelineinfectiousperitonitisbasedonclinicallaboratoryindicatorsandphysicalsigns